TP

Thomas Pfisterer

North America, Massachusetts, United States, Cambridge

Description

Thomas Pfisterer is the Head of Direct Investments at Wild Group Management. He is also a Board Member at Imvax.

Investor Profile

Thomas Pfisterer has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Switzerland.
  • Strong thematic focus on Health Care, Health Diagnostics, Medical.

Stage Focus

  • Series B (100%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Health Care
  • Health Diagnostics
  • Medical
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Thomas Pfisterer frequently co-invest with?

Speedinvest
Europe, Wien, Austria, Vienna
Co-Investments: 1
Walter Ventures
Europe, Bayern, Germany, Munich
Co-Investments: 1

What are some of recent deals done by Thomas Pfisterer?

Bloom Diagnostics

Zürich, Zurich, Switzerland

Bloom builds smart medical tests for consumers by combining diagnostics technology with medical knowledge and data.

Health CareHealth DiagnosticsMedicalPersonal Health
Series BMay 31, 2020
Amount Raised: $11,115,817